5A2-SC8
Recommended because it shares a closely related research category or delivery context. Formulation and performance are product- and study-specific.
View product →
Ionizable lipid for LNP and nucleic-acid delivery research.
Lipid 35 is an novel ionizable lipid designed to enhance the delivery of mRNA to specific tissues, particularly the lungs.Lipid 35 demonstrates superior chemical stability, especially in storage conditions. This stability ensures that the lipid maintains its integrity over extended periods, making it ideal for long-term storage and large-scale production.Lipid 35 exhibits high transfection efficiency in various cell types, including nonimmune cells, endothelial cells, and epithelial cells. Lipid 35 has demonstrated excellent biocompatibility and safety in preclinical studies. It does not cause significant liver damage or adverse immune responses, making it a safer alternative for therapeutic applications.
| CAS No. | Not available |
| Chemical Name | Lipid 35 |
| Synonyms | Lipid-35, Lipid35 |
| SMILES | CCCCCCCCC(CCCCCC)C(=O)OCCCCCCCCN(CCCCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCNC(=O)NCCCN(C)C |
| Formula | C56H112O5N4 |
| M.Wt | 921.53 |
| Purity | ELSD-HPLC>95% |
| Storage | Pure form: −20 °C, 1 year; In solvent: −80 °C, 6 months; −20 °C, 1 month. Sealed and protected from light. |
| Shipping condition | Ships from Shanghai. Pure lipid is stable during ice-pack transport. |
| Publication | Not available |
The product molecular weight is prefilled when available and remains editable. Confirm solvent compatibility and solubility before preparation.
Solvent volumes update from the molecular weight above.
| Mass | 1 mM | 5 mM | 10 mM |
|---|---|---|---|
| 10 mg | 10.8515 mL | 2.1703 mL | 1.0852 mL |
| 25 mg | 27.1288 mL | 5.4258 mL | 2.7129 mL |
| 50 mg | 54.2576 mL | 10.8515 mL | 5.4258 mL |
| 100 mg | 108.5152 mL | 21.7030 mL | 10.8515 mL |
| 250 mg | 271.2880 mL | 54.2576 mL | 27.1288 mL |
Contact our team with the catalog number and requested quantity.